首页> 外文期刊>Advances in Experimental Medicine and Biology >It's Not the Destination, It's the Journey: Heterogeneity in mRNA Export Mechanisms
【24h】

It's Not the Destination, It's the Journey: Heterogeneity in mRNA Export Mechanisms

机译:它不是目的地,这是旅程:mRNA出口机制的异质性

获取原文
获取原文并翻译 | 示例
           

摘要

The process of creating a translation-competent mRNA is highly complex and involves numerous steps including transcription, splicing, addition of modifications, and, finally, export to the cytoplasm. Historically, much of the research on regulation of gene expression at the level of the mRNA has been focused on either the regulation of mRNA synthesis (transcription and splicing) or metabolism (translation and degradation). However, in recent years, the advent of new experimental techniques has revealed the export of mRNA to be a major node in the regulation of gene expression, and numerous large-scale and specific mRNA export pathways have been defined. In this chapter, we will begin by outlining the mechanism by which most mRNAs are homeostatically exported ("bulk mRNA export"), involving the recruitment of the NXF1/TAP export receptor by the Aly/REF and THOC5 components of the TREX complex. We will then examine various mechanisms by which this pathway may be controlled, modified, or bypassed in order to promote the export of subset(s) of cellular mRNAs, which include the use of metazoan-specific orthologs of bulk mRNA export factors, specific cis RNA motifs which recruit mRNA export machinery via specific trans-acting-binding factors, posttranscriptional mRNA modifications that act as "inducible" export cis elements, the use of the atypical mRNA export receptor, CRM1, and the manipulation or bypass of the nuclear pore itself. Finally, we will discuss major outstanding questions in the field of mRNA export heterogeneity and outline how cutting-edge experimental techniques are providing new insights into and tools for investigating the intriguing field of mRNA export heterogeneity.
机译:创建平移竞争力mRNA的过程非常复杂,涉及许多步骤,包括转录,剪接,添加修饰,以及最终出口到细胞质。从历史上看,大部分关于MRNA水平的基因表达调节的大部分都集中在mRNA合成(转录和剪接)或代谢(转换和降解)的调节。然而,近年来,新的实验技术的出现揭示了mRNA的出口是在调节基因表达中的主要节点,并且已经确定了许多大规模和特异性的mRNA出口途径。在本章中,我们将首先概述大多数MRNA常驻出口的机制(“批量mRNA出口”),涉及通过TREX复合体的ALY / REF和THOC5组件招聘NXF1 / Tap Export受体。然后,我们将检查可以控制,修改或绕过的各种机制,以便促进细胞mRNA的子集的出口,其包括使用批量级mRNA出口因子的甲卓特异性直肠,具体的顺应性通过特异性转作绑定因子招出mRNA出口机制的RNA基序,其发布作为“诱导”出口顺式元素,使用非典型mRNA出口受体,CRM1和核心孔本身的操纵或旁路的使用。最后,我们将讨论MRNA导出异质性领域的主要出色问题,并概述了尖端的实验技术如何提供新的见解和工具,用于研究MRNA导出异质性的有趣领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号